Used primarily in the treatment of prostate cancer, this compound acts as an antiandrogen, blocking the effects of androgens like testosterone in the body. It is commonly prescribed in combination with a gonadotropin-releasing hormone (GnRH) analog for patients with advanced prostate cancer. By inhibiting androgen receptor signaling, it helps slow tumor growth and disease progression. It may also be used in other conditions involving androgen excess, such as in some cases of hirsutism or as part of gender-affirming hormone therapy in transgender women. Its oral bioavailability and once-daily dosing make it a convenient option in long-term treatment regimens.